Comparison

KRAS inhibitor-18 European Partner

Item no. HY-146476-1ea
Manufacturer MedChem Express
CASRN 2230873-66-0
Amount 1 ea
Category
Type Inhibitors
Specific against other
Formula C20H15ClF3N3O2S
Citations [1]Brian alan, et al. KRAS g12c inhibitors and methods of using the same. WO2018119183 A2
Smiles C=CC(N1CCN(CC1)C2=C3C=C(C(C4=CC(O)=C(C=C4F)F)=C(C3=NS2)F)Cl)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
KRAS inhibitor-18 (compound 3-10) is a potent KRAS G12C inhibitor with an IC50 of 4.74 µM. KRAS inhibitor-18 shows p-ERK inhibition activities with IC50s of 66.4, 11.1 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-18 has the potential for the research of pancreatic, colorectal, and lung cancers[1].
Shipping
Room temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
453.87
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
10 mM in DMSO
Manufacturers Target
Ras
Isoform
K-Ras
Pathway
GPCR/G Protein; MAPK/ERK Pathway
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close